- Home
- NRIX vs SPB Comparison
NRIX vs SPB Comparison
Compare NRIX & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | SPB |
|---|---|---|
| Founded | 2009 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NRIX | SPB |
|---|---|---|
| Price | $17.75 | $78.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $30.50 | ★ $82.40 |
| AVG Volume (30 Days) | ★ 874.4K | 376.1K |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.16 |
| Revenue | $76,987,000.00 | ★ $3,802,100,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $48.05 | $1.85 |
| P/E Ratio | ★ N/A | $36.30 |
| Revenue Growth | ★ 99.31 | 20.86 |
| 52 Week Low | $8.20 | $49.99 |
| 52 Week High | $22.50 | $86.96 |
Technical Indicators
Market Signals| Indicator | NRIX | SPB |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 50.57 |
| Support Level | $17.21 | $77.74 |
| Resistance Level | $19.98 | $80.42 |
| Average True Range (ATR) | 0.80 | 2.93 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 88.45 | 71.57 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.